- Home
- HII vs BMRN Comparison
HII vs BMRN Comparison
Compare HII & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HII
- BMRN
- Stock Information
- Founded
- HII 1886
- BMRN 1996
- Country
- HII United States
- BMRN United States
- Employees
- HII N/A
- BMRN N/A
- Industry
- HII Marine Transportation
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HII Industrials
- BMRN Health Care
- Exchange
- HII Nasdaq
- BMRN Nasdaq
- Market Cap
- HII 11.1B
- BMRN 9.9B
- IPO Year
- HII N/A
- BMRN 1999
- Fundamental
- Price
- HII $315.61
- BMRN $54.79
- Analyst Decision
- HII Buy
- BMRN Buy
- Analyst Count
- HII 5
- BMRN 19
- Target Price
- HII $320.60
- BMRN $90.26
- AVG Volume (30 Days)
- HII 510.2K
- BMRN 2.8M
- Earning Date
- HII 10-30-2025
- BMRN 10-27-2025
- Dividend Yield
- HII 1.76%
- BMRN N/A
- EPS Growth
- HII N/A
- BMRN 59.53
- EPS
- HII 14.50
- BMRN 2.68
- Revenue
- HII $12,012,000,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- HII $5.27
- BMRN $13.32
- Revenue Next Year
- HII $4.89
- BMRN $7.51
- P/E Ratio
- HII $21.57
- BMRN $20.23
- Revenue Growth
- HII 2.60
- BMRN 12.39
- 52 Week Low
- HII $158.88
- BMRN $50.76
- 52 Week High
- HII $330.00
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- HII 59.26
- BMRN 55.81
- Support Level
- HII $299.07
- BMRN $50.76
- Resistance Level
- HII $327.98
- BMRN $55.34
- Average True Range (ATR)
- HII 10.09
- BMRN 1.76
- MACD
- HII -0.16
- BMRN 0.34
- Stochastic Oscillator
- HII 56.26
- BMRN 68.29
About HII Huntington Ingalls Industries Inc.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia and Columbia-class nuclear submarines. Huntington Ingalls shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's Mission Technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.